Description
Recombinant monoclonal antibody to CCL2/CCL12. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma 11k2. This chimeric human antibody was made using the variable domain sequences of the original mouse IgG1 format for improved compatibility with existing reagents, assays and techniques.
Target
CCL2/CCL12
Target Alias Names
cytokine A2, MCP-1, Monocyte chemotactic factor 1, MCP-5, CCL12
Isotype/Mimetic
F(ab)2
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
recombinantly reformatted hybridoma (from pre-2020 immunisation)
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression